Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-002351-33-IT
EUCTR2006-002351-33-IT
Active, not recruiting
Not Applicable

Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - ND

AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA0 sitesDecember 4, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060
DrugsAVASTIN*INFUS 1FL 100MG

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Macular oedema
Sponsor
AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 4, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA

Eligibility Criteria

Inclusion Criteria

  • •Patients with vascular diseases of the eye, complicated by essudative maculopathy refractory to previous treatment or in which standard therapy is contraindicated or so severe that a favorable response is unpredictable.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Uncontrolled hypertension, coagulation abnormalities, renal or hepatic impairment, myocardial infarction, neoplasms, pregnant or breast\-feading women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSA
EUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
Unknown
Phase 1
To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalizatioARMD,BRVO,CRVO,DR,CNV
JPRN-UMIN000000647Department of Ophtalmology of Keio University Hospital10
Active, not recruiting
Not Applicable
Safety and efficacy of intravitreal injections of ranibizumab/Lucentis in combination with verteporfin photodynamic therapy (PDT) in patients with choroidal neovascularisation (CNV) secondary to age related macular degeneratio
EUCTR2006-002977-33-SIniversity Eye Hospital10
Recruiting
Not Applicable
Study of the efficacy and safety of intra-retinal arterial fibrinolysis for central retinal artery occlusioCentral Retinal Artery Occlusion(CRAO)
JPRN-UMIN000022972Yokohama City University10
Completed
Not Applicable
Evaluation of treatment options of central serous chorioretinopathyCentral Serous Chorioretinoathy.Central Serous Chorioretinopathy
IRCT2017041533448N1Vice chancellor for research, Zahedan University of Medical Sciences30